KZKsenya N. Zhigalova

Ksenya N. Zhigalova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ksenya N. Zhigalova has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Tatiana V. Priputnevich

    Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health, 117997 Moscow, Russia

    6 shared publications
  • Vera V. Muravieva

    V.I. Kulakov Obstetrics, Gynecology and Perinatology National Medical Research Center, Ministry of Health of the Russian Federation, Moscow

    5 shared publications
  • Aleksey V. Skorobogatiy

    National Medical Research Center of Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov of the Ministry of Health of the Russian Federation, 117997 Moscow, Russia

    4 shared publications
  • Galina E. Chernukha

    V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Healthcare of Russian Federation, 117997 Moscow, Russia

    4 shared publications
  • Pavel Denisov

    National Medical Research Center of Obstetrics, Gynecology and Perinatology Named After Academician V.I. Kulakov, Ministry of Health of the Russian Federation, 117997 Moscow, Russia

    4 shared publications
  • Elena L. Isaeva

    National Medical Research Center of Obstetrics, Gynecology and Perinatology Named After Academician V.I. Kulakov, Ministry of Health of the Russian Federation, 117997 Moscow, Russia

    3 shared publications

Latest Publications

  • Open Access

    The Impact of Antimicrobial Therapy on the Development of Microbiota in Infants

    by Tatiana Priputnevich, Pavel Denisov, Ksenia Zhigalova, Vera Muravieva, Natalia Shabanova, Alexey Gordeev, Viktor Zubkov, Bayr Bembeeva, Elena Isaeva, Anastasia Nikolaeva, et al.

    Background. The establishment and diversity of the gut microbiota during early childhood are fundamental for immune regulation and metabolic processes, with factors such as prematurity, delivery method, antibiotic treatment, and breastfeeding significantly impacting microbiome development and potential health outcomes. Objectives/Methods. This comparative study examined the gut microbiota composition in children aged 6–8 and 9–12 months, born via spontaneous labor at ≥38 weeks’ gestation, who either did not receive antibacterial therapy or required beta-lactam antibiotics. The composition of the colonic microbiota was analyzed in these fecal samples using a quantitative real-time PCR (qRT-PCR). Results. Significant differences in microbiota composition were observed between groups. Children treated with antibiotics exhibited a statistically significant reduction in alpha diversity indices (Shannon and Simpson), along with decreased colonization of key functionally important microorganisms, including obligate anaerobic bacteria such as Faecalibacterium prausnitzii, Clostridium leptum, Bacteroides spp., and metabolically active Bifidobacteria (B. bifidum, B. breve, B. longum). Conclusions. These microbiota alterations may adversely affect child health by diminishing microbial balance and functional potential, especially during this critical period of immune and metabolic development. The decline in anti-inflammatory, short-chain fatty acid-producing bacteria elevates the risk for allergic, atopic, dysbiotic, and metabolic conditions. Recognizing these impacts underscores the importance of strategies to supports microbiota restoration after antibiotic use, such as probiotics, prebiotics, and dietary interventions. Further research should focus on microbiota recovery dynamics to facilitate early intervention and optimize pediatric health outcomes. Overall, understanding antibiotic effects on gut microbiota can guide more judicious treatment approaches, reducing long-term health risks.

  • Open Access

    Gut Microbial Composition on Dienogest Therapy in Patients with Endometriosis

    by Veronika Pronina, Pavel Denisov, Vera Muravieva, Alexey Skorobogatiy, Ksenia Zhigalova, Galina Chernukha, Gennady Sukhikh, Tatiana Priputnevich

    Endometriosis is a chronic inflammatory condition affecting approximately 10% of women of reproductive age, characterized by pelvic pain, dysmenorrhea, and infertility. Emerging evidence suggests a potential link between gut microbiota dysbiosis and endometriosis pathogenesis, mediated through hormonal regulation, immune modulation, and systemic inflammation. Dienogest (DNG) is widely used for endometriosis management, but its effects on gut microbiota remain underexplored. This study investigates the impact of DNG on gut microbial composition in endometriosis patients, aiming to elucidate its therapeutic mechanisms beyond hormonal modulation. DNG therapy led to a significant reduction in the Bacillota/Bacteroidota ratio (p = 0.0421), driven by decreased Staphylococcus spp. (p = 0.0244) and increased commensal bacteria such as Lactobacillus spp. and Collinsella aerofaciens (p = 0.049). Species richness and alpha diversity indices showed a non-significant upward trend. Notably, C. aerofaciens, a butyrate producer linked to gut barrier integrity, was detected twice as frequently during therapy. The study also observed reductions in facultative anaerobes like Enterococcus spp. and a trend toward higher titers of beneficial Bacteroidota. This study provides the first evidence that DNG therapy modulates gut microbiota in endometriosis patients, favoring a composition associated with anti-inflammatory and barrier-protective effects. The observed shifts—reduced opportunistic pathogens and increased symbionts—suggest a novel mechanism for DNG’s efficacy, potentially involving the microbial regulation of estrogen metabolism and immune responses.


  • Open Access

    Rapid Raman spectroscopy-based test for antimicrobial resistance

    by Vladimir Mushenkov, Ksenia Zhigalova, Pavel Denisov, Alexey Gordeev, Dmitry Lukyanov, Vladimir Kukushkin, Tatiana Priputnevich, Elena Zavyalova

    Antimicrobial resistance (AMR) is one of the top global health threats. In 2019, AMR was associated with 4.95 million deaths, of which 1.97 million were caused by drug-resistant infections directly. The main subset of AMR is antibiotic resistance, that is, the resistance of bacteria to antibiotic treatment. Traditional and most commonly used antibiotic susceptibility tests are based on the detection of bacterial growth and its inhibition in the presence of an antimicrobial. These tests typically take over 1–2 days to perform, so empirical therapy schemes are often administered before proper testing. Rapid tests for AMR are necessary to optimize the treatment of bacterial infection. Here, we combine the MTT test with Raman spectroscopy to provide a 1.5 h long test for minimal inhibitory concentration determination. Several Escherichia coli and Klebsiella pneumoniae strains were tested with three types of antibiotics, including ampicillin from penicillin family, kanamycin from aminoglycoside family and levofloxacin from fluoroquinolone family. The test provided the same minimal inhibitory concentrations as traditional Etest confirming its robustness.


  • Open Access

    Optimising Conditions for the Preservation of Extremely Oxygen Sensitive Obligate Anaerobes of the Gut Microbiota as Candidates for Probiotic Strains

    by Б. О. Бембеева, E. L. Isaeva, V. V. Muravieva, K. N. Zhigalova, O. V. Nechaeva, D. Kh. Bazukheyr, T. V. Priputnevich, Д. Х. Базухейр

    Obligate anaerobic difficult culture bacteria, which make up the bulk of the microbiota of the large intestine, are potential candidates for the development of highly effective new generation probiotics, since they are capable of synthesizing a variety of metabolites, including short-chain fatty acids, which have a stimulating effect on both commensal bacteria and host cells. However, for their long-term preservation, it is necessary to carefully select the preservation method and protective components. To evaluate the efficacy of using different cryoprotectants to increase the viability of obligate anaerobic difficult culture bacteria when preserved by lyophilisation and cryopreservation methods. The studies showed that freeze-drying contributed most to the preservation of the viability of Faecalibacterium prausnitzii, Anaerostipes hadrus, Eubacterium hallii, provided that they were used as a stabilizing medium, which included inulin, cysteine and riboflavin, ensuring the preservation of the initial bacterial titer for 30 days. Among the studied bacteria, the effectiveness of cryopreservation was shown for A. hadrus, since it ensured the survival of bacteria at the initial level for 14 days of storage, regardless of the cryopreservative used, but by the 30th day their viability decreased significantly (by 100 times when using liquid as a cryopreservant). nutrient medium 110 with minced meat and carbohydrates with the addition of glycerin, 10 000 with the commercial cryopreservative CRYOINSTANT). The results obtained allow us to recommend lyophilization as the most optimal method for long-term storage of probiotic strains of bacteria using highly effective stabilizers.


  • Open Access

    Comprehensive Study of Intestinal Microbiota Using Molecular Genetic and Cultural Methods with an Assessment of the Role of Fecal Biomarkers in Endometriosis

    by V.A. Pronina, Russian Federation Moscow, G.E. Chernukha, K.N. Zhigalova, A.V. Skorobogatiy, P.а. Denisov, T.V. Priputnevich

    Aim. Analysis of the composition of intestinal microbiota in patients with endometriosis and determination of the potential value of fecal biomarkers in the diagnosis of the disease. Design. Сross-sectional, single-center clinical study. Materials and methods. The clinical and anamnestic data of 260 women with endometriosis (mean age 28 (25; 33) years) were analyzed. A comparison group of 130 age-matched women without signs of genital endometriosis was selected to study symptoms and comorbid conditions of endometriosis. In order to measure the concentrations of fecal markers, 56 women of the main group and 21 of the comparison group were randomized, fecal samples of 37 patients with endometriosis and 22 women of the comparison group were selected for microbiological examination. Microbiological examination of fecal samples was performed by culture and quantitative real-time polymerase chain reaction (PCR) methods, and the concentrations of fecal markers (calprotectin, hemoglobin, transferrin) were estimated by the HTSA Plus immunochemical method in the same biological material. Results. Every 4th patient with endometriosis had complaints of dyschezia (68/260, 26.2%), and more than 60% reported changes in stool character during menstruation in the form of loosening or constipation (161/260, 61.9%). Analysis of gastrointestinal tract (GIT) pathology showed that 77 (29.6%) patients had concomitant organic GIT diseases, i. e. 1.4 times more often than in the comparison group, 60 (23,1%) had irritable bowel syndrome (IBS). The presence of complaints of stool changes during menstruation increased the chances of diagnosing endometriosis 2-fold, concomitant IBS — 5-fold, and dyschezia more than 16-fold. Every 2nd patient with endometriosis (27/56, 48.2%) had a fecal calprotectin concentration greater than reference values, which was also positively correlated with symptoms of intestinal dysbiosis (r = 0.397, p = 0.0025). Analysis of the composition of the intestinal microbiota showed a decrease in species richness, an increase in the frequency and titer of opportunistic microorganisms and a decrease in the colonization of symbiont bacteria in endometriosis. The realtime PCR method had advantages for additional detection of complexly cultured microorganisms; a decrease in the titer of symbiont bacteria of the Clostridium leptum gr. cluster (p = 0.02808), Faecalibacterium prausnitzii (p = 0.03635) and Akkermansia muciniphila (p = 0.05297), microorganisms of the family of the genus Desulfovibrio (p = 0.04852) was detected. Conclusion. An important stage of clinical and anamnestic examination of patients with endometriosis, in addition to the detection of IBS, is the assessment of the presence of organic pathology of the gastrointestinal tract and a number of gastrointestinal symptoms, which can increase the chances of diagnosing endometriosis up to 16 times. Studying the composition of the intestinal microbiota in endometriosis is a promising direction, it is advisable to comprehensively determine the microbial composition by culture and quantitative real-time PCR methods using an extended multiplex panel. Measurement of faecal marker levels seems to be a promising but insufficiently studied method for non-invasive diagnosis of endometriosis, which requires additional studies with a larger sample of patients with colorectal endometriosis. Keywords: endometriosis, intestinal microbiota, culturomics, real-time polymerase chain reaction, faecal calprotectin.

  • Open Access

    The effect of oral progestogens on the intestinal microbiota composition in patients with endometriosis: pilot study

    by V. A. Pronina, A. B. Gordeev, V. V. Murav’eVa, A. V. Skorobogatyy, K. N. Zhigalova, P. A. Denisov, G. E. Chernukha, T. V. Priputnevich

    Today, the contribution of the microbiota to the genesis of many diseases, including endometriosis, is widely discussed. However, the literature data on the microbiological composition of endometriosis are contradictory. In addition, data indicating the effect of conservative therapy on the microbiological composition are limited only to estrogen-containing drugs, while there is no data on the effect of progestogens. Objective: to evaluate the composition of the intestinal microbiota of patients with external genital endometriosis on oral progestogen therapy. A single-stage pilot study was conducted, which included 17 patients with external genital endometriosis (average age 30.9 (7.8) years, average body mass index 20.2 (2.0) kg/m2 ). The women received oral progestogen therapy (dienogest at a dose of 2 mg per day in a continuous mode). Microbiological examination of faecal samples by culturomics methods with inoculation on selective and non-selective nutrient media, followed by species identification of microorganisms, was carried out using time-of-flight mass spectrometry (MALDI-TOF MS) at two points: initially and after 6 months of taking dienogest. Dienogest therapy showed an improvement in a number of microbiological indicators of the intestinal microbiota in the form of a tendency to increase species and taxonomic diversity, a decrease in the Bacillota / Bacteroidota index, and a decrease in the titer of conditionally pathogenic microorganisms Staphylococcus spp. and increased colonization of symbiotic bacteria of the Collinsella aerofaciens and Lactobacillus spp. Thus, dienogest therapy can have both a direct and indirect effect on the composition of the intestinal microbiota of patients with external genital endometriosis, which was demonstrated by the results of the study.

  • Open Access

    Features of the Gut Microbiota in Patients with Polycystic Ovary Syndrome

    by Ekaterina D. Kirillova, Vera V. Muravieva, Elena L. Isaeva, Aleksey V. Skorobogatiy, Ksenya N. Zhigalova, Anastasia A. Kozlova, Tatiana V. Priputnevich, Galina E. Chernukha

    Background. Polycystic ovary syndrome (PCOS) is the most common endocrinopathy associated with infertility and metabolic disorders. The ethology and pathogenesis of PCOS are not fully understood. The role of gut microbiota (GM) disorders in the genesis of insulin resistance and in the development of PCOS is ambiguous. Aims to compare the GM of patients with PCOS and healthy women, to evaluate the relationship of various groups of microorganisms with markers of chronic inflammation. Methods. A single-center cross-sectional study was conducted involving 148 women: 118 with PCOS and 30 somatically healthy women aged 1840 years. A comprehensive clinical, laboratory and instrumental examination was performed, as well as an assessment of the composition of the GM using the cultural analysis method. Results. In PCOS, a decrease in the GM diversity Margalef index was revealed compared to healthy women. A statistically significant decrease in the level of colonization of Bacteroides (B. vulgatus, B. eggerthii, B. caccae), Lactobacillus gasseri, Lacticaseibacillus rhamnosus, Escherichia coli (E.coli) and, on the contrary, an increase in the population of gamma-proteobacteria of the family Enterobacteriaceae and beta-proteobacteria of the order Burkholderiales, as well as Erysipelatoclostridium ramosum (E. ramosum), compared with healthy women. Correlation analysis revealed a negative correlation of bacteria of the genera Lactobacillus, Bifidobacterium, Bacteroides with IL-6, as well as E. coli with IL-6 and C-reactive protein in patients with PCOS. A positive correlation was observed between the level of IL-6 and the abundance of bacteria of the species E. ramosum. Conclusions. The GM of PCOS patients is characterized by a decrease in Margalef diversity index, aggravated by the imbalance in microbial communities, accompanied by an increase in the levels of pro-inflammatory markers, compared with healthy women.